Cargando…

MmpS5-MmpL5 Transporters Provide Mycobacterium smegmatis Resistance to imidazo[1,2-b][1,2,4,5]tetrazines

The emergence and spread of drug-resistant Mycobacterium tuberculosis strains (including MDR, XDR, and TDR) force scientists worldwide to search for new anti-tuberculosis drugs. We have previously reported a number of imidazo[1,2-b][1,2,4,5]tetrazines–putative inhibitors of mycobacterial eukaryotic-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maslov, Dmitry A., Shur, Kirill V., Vatlin, Aleksey A., Danilenko, Valery N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157563/ https://www.ncbi.nlm.nih.gov/pubmed/32121069 http://dx.doi.org/10.3390/pathogens9030166

Ejemplares similares

Draft Genome Sequences of 12 Mycolicibacterium smegmatis Strains Resistant to Imidazo[1,2-b][1,2,4,5]Tetrazines
por: Vatlin, Aleksey A., et al.
Publicado: (2019)

Transcriptomic dataset of Mycolicibacterium smegmatis exposed to an imidazo[1,2-b][1,2,4,5]tetrazine
por: Vatlin, Aleksey A., et al.
Publicado: (2020)

Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis: A Combined In Silico and In Vitro Study
por: Shahbaaz, Mohd, et al.
Publicado: (2022)

Transcriptomic Profile of Mycobacterium smegmatis in Response to an Imidazo[1,2-b][1,2,4,5]tetrazine Reveals Its Possible Impact on Iron Metabolism
por: Vatlin, Aleksey A., et al.
Publicado: (2021)

Coexpression of MmpS5 and MmpL5 Contributes to Both Efflux Transporter MmpL5 Trimerization and Drug Resistance in Mycobacterium tuberculosis
por: Yamamoto, Kentaro, et al.
Publicado: (2021)

Resistance against Membrane-Inserting MmpL3 Inhibitor through Upregulation of MmpL5 in Mycobacterium tuberculosis
por: Li, Ming, et al.
Publicado: (2020)

Kanamycin and Ofloxacin Activate the Intrinsic Resistance to Multiple Antibiotics in Mycobacterium smegmatis
por: Vatlin, Aleksey A., et al.
Publicado: (2023)

Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors
por: McNeil, Matthew B., et al.
Publicado: (2020)

Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis
por: Grover, Shipra, et al.
Publicado: (2020)

Synthesis of novel [1,2,4]triazolo[1,5-b][1,2,4,5]tetrazines and investigation of their fungistatic activity
por: Korotina, Anna V, et al.
Publicado: (2022)

Exploration of High‐Energy‐Density Materials: Computational Insight into Energetic Derivatives Based on 1,2,4,5‐Tetrahydro‐1,2,4,5‐tetrazine
por: Jin, Xinghui, et al.
Publicado: (2018)

MmpL Proteins in Physiology and Pathogenesis of M. tuberculosis
por: Melly, Geoff, et al.
Publicado: (2019)

Molecular Mechanisms of MmpL3 Function and Inhibition
por: Williams, John T., et al.
Publicado: (2023)

N′-[6-(3,5-Dimethylpyrazol-1-yl)-1,2,4,5-tetrazin-3-yl]propanohydrazide
por: Yan, Qi-dong, et al.
Publicado: (2010)

Corrigendum: Exploration of High‐Energy‐Density Materials: Computational Insight into Energetic Derivatives Based on 1,2,4,5‐Tetrahydro‐1,2,4,5‐tetrazine
por: Jin, Xinghui, et al.
Publicado: (2019)

3-Phenyl-6-(2-pyridyl)-1,2,4,5-tetrazine
por: Chartrand, Daniel, et al.
Publicado: (2007)

Synthesis and radiolabeling of a polar [(125)I]I‐1,2,4,5‐tetrazine
por: Bidesi, Natasha, et al.
Publicado: (2022)

Identification of Mutations Conferring Tryptanthrin Resistance to Mycobacterium smegmatis
por: Frolova, Svetlana G., et al.
Publicado: (2020)

Synthesis of pyrido-annelated [1,2,4,5]tetrazines, [1,2,4]triazepine, and [1,2,4,5]tetrazepines for anticancer, DFT, and molecular docking studies
por: Hassan, Aisha Y., et al.
Publicado: (2023)

1-Benzoyl-3,6-diphenyl-1,4-dihydro-1,2,4,5-tetrazine
por: Xu, Feng, et al.
Publicado: (2010)

Direct Inhibition of MmpL3 by Novel Antitubercular Compounds
por: Li, Wei, et al.
Publicado: (2019)

Targeting MmpL3 for anti-tuberculosis drug development
por: Bolla, Jani R.
Publicado: (2020)

3,6-Di-4-pyridyl-1,4-dihydro-1,2,4,5-tetrazine
por: Wang, Hai, et al.
Publicado: (2008)

3,6-Diacetyl-1,4-diphenyl-1,4-dihydro-1,2,4,5-tetrazine
por: Al-Noaimi, Mousa, et al.
Publicado: (2008)

4,4′-(1,2,4,5-Tetrazine-3,6-diyl)dibenzonitrile
por: Dutkiewicz, Grzegorz, et al.
Publicado: (2009)

1,2,4,5-Tetrazine-tethered probes for fluorogenically imaging superoxide in live cells with ultrahigh specificity
por: Jiang, Xuefeng, et al.
Publicado: (2023)

MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and Corynebacteria
por: Varela, Cristian, et al.
Publicado: (2012)

Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro
por: Li, Wei, et al.
Publicado: (2017)

6-(3,5-Dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazin-3(2H)-one
por: Suponitsky, Kyrill Yu., et al.
Publicado: (2013)

Mechanism, Kinetics and Thermodynamics of Decomposition for High Energy Derivatives of [1,2,4]Triazolo[4,3-b][1,2,4,5]tetrazine
por: Stankevich, Aleksandr V., et al.
Publicado: (2022)

N′-[6-(3,5-Dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazin-3-yl]butanohydrazide
por: Yan, Qi-Dong, et al.
Publicado: (2011)

Use of Soluble Extracellular Regions of MmpL (SERoM) as Vaccines for Tuberculosis
por: Strong, Emily J., et al.
Publicado: (2018)

Structure-function analysis of MmpL7-mediated lipid transport in mycobacteria
por: Moolla, Nabiela, et al.
Publicado: (2021)

N (1),N (4),3,6-Tetramethyl-1,2,4,5-tetrazine-1,4-dicarboxamide
por: Sun, Na-Bo, et al.
Publicado: (2012)

Matrix metalloproteinases (MMP’s) in the rat scoliotic intervertebral disc
por: Grivas, Theodoros B, et al.
Publicado: (2010)

DFT-based reactivity and combined QSAR, molecular docking of 1,2,4,5-Tetrazine derivatives as inhibitors of Pim-1 kinase
por: Hazhazi, Halima, et al.
Publicado: (2019)

MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections
por: Li, Wei, et al.
Publicado: (2018)

Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria
por: Fay, Allison, et al.
Publicado: (2019)

Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression
por: Degiacomi, Giulia, et al.
Publicado: (2017)

MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections
por: Sethiya, Jigar P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ghuvepiq5np66nr7ti6qlln8ca